Dr. Laurence S. Sperling appointed incoming Chief Medical Officer (CMO), focused on programs that aim to dramatically increase screening and diagnosis of Americans living with the two common genetic causes of stroke and heart attacks, elevated lipoprotein(a) and familial hypercholesterolemia Credit: Family Heart Foundation